UPDATE 4-Roche to buy U.S. biotech firm InterMune for $8.3 bln By: Reuters: Company News August 25, 2014 at 04:27 AM EDT * Consensus 2019 sales for InterMune lung drug $1.04 bln (Adds additional analyst comment, shares) Read More >> Related Stocks: AbbVie Alexion Pharmaceuticals Astrazeneca Plc ADR Biomarin Pharmaceuticals Illumina Inc Pfizer Rogers Corp